固体脂质纳米颗粒通过自然肥的凝聚:为口服输送胰岛素类似物的初步研究
Annalisa Bozza1, Arianna Marengo1, Federica Blua1
1Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Pharmaceutics
|October 29, 2025
概括
口服胰岛素输送面临挑战,但固体脂质纳米颗粒显示出有前途. 这项研究开发了用于增强胰岛素吸收的纳米粒子配方和口服剂型,表明了口服胰岛素治疗的可行途径.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
背景情况:
- 口服胰岛素的输送受到肠道吸收不良和酶降解的阻碍.
- 基于纳米粒子的输送系统为克服这些障碍提供了潜在的解决方案.
研究的目的:
- 开发和评估固体脂质纳米颗粒用于口服注射格拉素胰岛素.
- 从这些纳米粒子中创建稳定,可重新分散的口服固体剂型.
主要方法:
- 格拉素胰岛素被装入固体脂质纳米颗粒中,使用与芝麻和果肥的联合化.
- 活体结合肠道实验评估了透率.
- 使用冷干燥和喷雾干燥来创建固体剂型.
主要成果:
- 固体脂质纳米粒子显著增强了肠道部分的透性.
- 喷雾干燥产生了一个可扩展,可重新分散的粉末配方.
- 这些纳米颗粒成功地被纳入粉末和片中.
结论:
- 工程化固体脂质纳米颗粒显示出有效的口服胰岛素输送的潜力.
- 开发的工艺适合创建固体口服剂型.
- 需要进一步的体内研究来评估药理疗效.
相关概念视频
Insulin Formulations: Types and Delivery
642
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
642
Colloids
20.6K
Children at play often make suspensions such as mixtures of mud and water, flour and water, or a suspension of solid pigments in water known as tempera paint. These suspensions are heterogeneous mixtures composed of relatively large particles that are visible to the naked eye or can be seen with a magnifying glass. They are cloudy, and the suspended particles settle out after mixing. On the other hand, a solution is a homogeneous mixture in which no settling occurs and in which the dissolved...
20.6K
Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
Bioavailability Enhancement: Drug Solubility Enhancement
212
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
212
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K


